Affordable Care Act insurers approved more claims in 2024, although the improvement remains modest.
Health Insurance Newsletter
New ACA proposals in the works as ‘subsidy cliff’ looms
As the Affordable Care Act “subsidy cliff” looms, reports say President Donald Trump plans to announce a new proposal for addressing health care costs.
Vitable Health released its inaugural Small Business Benefits Index, revealing significant perception gaps between small business employers and employees on healthcare access and affordability.
Health care reform must include addressing high costs
Federal cuts to Medicaid will end up increasing costs to the nation’s health care system as low-income people who lose their coverage will seek treatment in emergency rooms and other high-cost facilities.
A new report from Guardian Life found that the percentage of full-time working Americans who also manage caregiving duties for a loved one has risen sharply since 2019.
Affordable Care Act Marketplace premiums will rise an average of 20% nationwide in 2026, according to a new analysis by MoneyGeek.com, which reviewed rate filings from all 50 states and Washington, D.C.
A new study from New York Life Group Benefit Solutions highlights the growing realities faced by caregivers of people with special needs — an often-overlooked workforce segment balancing demanding care responsibilities with their professional lives.
Across the country, people are experiencing sticker shock when they open their annual insurance rate notices and discover their 2026 premium increases.
Cigna Healthcare, the health benefits division of The Cigna Group, announced the launch of Clearity by Cigna Healthcare, a copay-only health plan.
Senator proposes swapping ACA tax credits for prepaid HSAs
Sen. Bill Cassidy, (R-La.), introduced a plan that could significantly shift the landscape for those who obtain health insurance through the Affordable Care Act marketplace.
Medicare Supplement or Medicare Advantage? Which is best for you?
What do these plans include and who are they for?
About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, although the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.
Artificial intelligence is poised to transform workplace benefits, according to Transamerica’s new research report “Prescience 2030: The Next Wave.”
Outlook for extending enhanced ACA subsidies uncertain
The outlook for extending enhanced Affordable Care Act subsidies is uncertain, since the bill that ended the 43-day government shutdown did not include an extension of those subsidies.
As states completed the “unwinding” of pandemic-era continuous coverage, Medicaid enrollment fell 7.6% in FY 2025 and is expected to be largely flat in FY 2026, according to KFF’s 25th annual Medicaid Budget Survey.Â
The National Association of Benefits and Insurance Professionals welcomes the reopening of the federal government but cautions that the short-term funding measure offers only temporary stability while delaying action on the nation’s most pressing health care challenges affecting families, individuals, seniors, and businesses alike.
PBM reform: Employers are finding their own fix
Pharmacy costs remain one of the toughest challenges in employer-sponsored health plans, and comprehensive federal reform is likely a long way off.
Medicare to cover obesity drugs for certain groups next year
Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal the Trump administration struck with drugmakers Eli Lilly and Novo Nordisk.
As the government shutdown continues, public support remains high for extending the enhanced ACA tax credits set to expire at the end of the year, with three quarters (74%) of the public in favor of extending them, a new KFF Health Tracking Poll finds.
